DE2606516A1 - Entzuendungshemmendes mittel zur lokalen anwendung - Google Patents

Entzuendungshemmendes mittel zur lokalen anwendung

Info

Publication number
DE2606516A1
DE2606516A1 DE19762606516 DE2606516A DE2606516A1 DE 2606516 A1 DE2606516 A1 DE 2606516A1 DE 19762606516 DE19762606516 DE 19762606516 DE 2606516 A DE2606516 A DE 2606516A DE 2606516 A1 DE2606516 A1 DE 2606516A1
Authority
DE
Germany
Prior art keywords
hydrocortisone
propylene glycol
agent
inflammatory agent
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19762606516
Other languages
German (de)
English (en)
Other versions
DE2606516C2 (sk
Inventor
Martin Whitefield
Hyman Yarrow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diomed Developments Ltd
Original Assignee
DERMAL LAB Ltd
DERMAL LABORATORIES Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DERMAL LAB Ltd, DERMAL LABORATORIES Ltd filed Critical DERMAL LAB Ltd
Publication of DE2606516A1 publication Critical patent/DE2606516A1/de
Application granted granted Critical
Publication of DE2606516C2 publication Critical patent/DE2606516C2/de
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19762606516 1975-02-19 1976-02-18 Entzuendungshemmendes mittel zur lokalen anwendung Granted DE2606516A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7030/75A GB1543907A (en) 1975-02-19 1975-02-19 Steroid compositions

Publications (2)

Publication Number Publication Date
DE2606516A1 true DE2606516A1 (de) 1976-09-02
DE2606516C2 DE2606516C2 (sk) 1987-09-17

Family

ID=9825303

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762606516 Granted DE2606516A1 (de) 1975-02-19 1976-02-18 Entzuendungshemmendes mittel zur lokalen anwendung

Country Status (7)

Country Link
JP (1) JPS609486B2 (sk)
AU (1) AU502937B2 (sk)
DE (1) DE2606516A1 (sk)
FR (1) FR2341317A1 (sk)
GB (1) GB1543907A (sk)
IE (1) IE43270B1 (sk)
ZA (1) ZA76980B (sk)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0044543A1 (en) * 1980-07-18 1982-01-27 The Wellcome Foundation Limited Topical formulations of 9-(2-hydroxyethoxymethyl) guanine
FR2539991A1 (fr) * 1983-01-27 1984-08-03 Taisho Pharmaceutical Co Ltd Onguent gras contenant notamment du butyro-propionate d'hydrocortisone, son procede de preparation et son application therapeutique
FR2539992A1 (fr) * 1983-01-31 1984-08-03 Taisho Pharmaceutical Co Ltd Creme du type huile-dans-l'eau comprenant du butyro-propionate d'hydrocortisone, son procede de preparation et son application therapeutique
WO1996020712A1 (en) * 1994-12-30 1996-07-11 American Home Products Corporation Clear non-alcoholic hydrocortisone solutions

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR830005852A (ko) * 1980-07-18 1983-09-14 미첼 페터 잭슨 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법
AT389447B (de) * 1983-01-27 1989-12-11 Taisho Pharmaceutical Co Ltd Verfahren zur herstellung einer topischen steroidsalbe
GB2302808A (en) * 1995-07-04 1997-02-05 Surtech Int Ltd Propylene glycol with low potency corticosteroids for topical treatment of the scalp

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2355710A1 (de) * 1972-11-24 1974-05-30 Squibb & Sons Inc Creme zur lokalen anwendung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA725898B (en) * 1972-05-30 1973-05-30 Sackler R Iodophor steroid pharmaceutical compositions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2355710A1 (de) * 1972-11-24 1974-05-30 Squibb & Sons Inc Creme zur lokalen anwendung

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HORNE David C., The Journal of Hospital Pharmacy, Sept. 1974, S. 177-180 *
POULSEN, B. J., et al., J. Pharm. SCJ 57, 6(1968), S. 928-933 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0044543A1 (en) * 1980-07-18 1982-01-27 The Wellcome Foundation Limited Topical formulations of 9-(2-hydroxyethoxymethyl) guanine
FR2539991A1 (fr) * 1983-01-27 1984-08-03 Taisho Pharmaceutical Co Ltd Onguent gras contenant notamment du butyro-propionate d'hydrocortisone, son procede de preparation et son application therapeutique
FR2539992A1 (fr) * 1983-01-31 1984-08-03 Taisho Pharmaceutical Co Ltd Creme du type huile-dans-l'eau comprenant du butyro-propionate d'hydrocortisone, son procede de preparation et son application therapeutique
WO1996020712A1 (en) * 1994-12-30 1996-07-11 American Home Products Corporation Clear non-alcoholic hydrocortisone solutions

Also Published As

Publication number Publication date
AU502937B2 (en) 1979-08-16
IE43270B1 (en) 1981-01-28
JPS51106713A (sk) 1976-09-21
FR2341317B1 (sk) 1979-06-08
AU1123276A (en) 1977-08-25
GB1543907A (en) 1979-04-11
ZA76980B (en) 1977-01-26
JPS609486B2 (ja) 1985-03-11
DE2606516C2 (sk) 1987-09-17
IE43270L (en) 1976-08-19
FR2341317A1 (fr) 1977-09-16

Similar Documents

Publication Publication Date Title
DE69003652T2 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzündlicher und viraler hauterkrankungen.
DE2747631C3 (de) Salbe
DE3226224A1 (de) Verfahren zur isolierung von sterolen oder sterolmischungen
DE3402880A1 (de) Oel-in-wasser-creme und verfahren zu ihrer herstellung
CH643456A5 (de) Pharmazeutische zubereitung.
DE2623927C2 (de) Phytosterin-Gemisch, Verfahren zu seiner Herstellung und seine Verwendung
DE2818827C2 (de) Mittel zur Behandlung von Psoriasis
DE3411225C2 (sk)
DE3829641C2 (sk)
DE1617320C3 (de) Hautbehandlungsmittel
DE3836862A1 (de) Mittel zur transdermalen applikation von steroidhormonen
CH649923A5 (de) Topisch verabreichbare pharmazeutische zusammensetzungen, enthaltend anti-inflammatorische steroide.
DE2606516A1 (de) Entzuendungshemmendes mittel zur lokalen anwendung
DE4038385C2 (de) Sitosterol und seine Glykoside mit verbesserter Bioverfügbarkeit
DE3402877C2 (sk)
DE2609575C2 (de) Kosmetisches Präparat
DE2144249B2 (de) Emulsionskosmetikum
DE2851369A1 (de) Lokalanaesthetische emulsionscreme, verfahren zu deren herstellung und deren verwendung
EP0120224A2 (de) Funktionelles Ölcremebad
DE3020616C2 (sk)
DE2347243A1 (de) Pharmazeutische zusammensetzungen
DE69104556T2 (de) Haarwasser zur Behandlung von Haarausfall.
DE3047854A1 (de) Topische salbe
DE934665C (de) Verfahren zur Herstellung von Loesungen von Steroiden
EP0775517A1 (de) Wasser/Öl-Mischemulgator sowie dessen Verwendung in kosmetischen und pharmazeutischen Zubereitungen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8127 New person/name/address of the applicant

Owner name: DIOMED DEVELOPMENTS LTD., GOSMORE, HITCHIN, HERTFO

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee